Table 2.

HLA A, B, and C allele subtypes in Indian RSA patients

HLA	Patients (N = 40)		Controls (N = 46)		OR	χ2	EF	PF	P-value
	N+	AF (%)	N+	AF (%)
A*0101	12	15.00	11	11.95	1.4	0.009
A*02011	7	8.75	1	1.08	9.5	0.092	0.07		0.01
A*0211	8	10.00	12	13.04	0.7	0.001		0.03
A*030101	9	11.25	4	4.34	3.0	0.004	0.14		0.07*
A*11011	5	6.25	13	14.13	0.4	0.026		0.03	0.07
A*2402	17	21.25	28	30.43	0.5	0.025		0.18	0.06*
A*2601	3	3.75	1	1.08	3.6	0.033	0.02
A*31012	2	2.50	6	6.52	0.4	0.009		0.03
A*3303	10	12.50	5	5.43	2.7	0.047	0.07		0.08
A*68011	7	8.75	2	2.17	4.7	0.064	0.06		0.04
B*0702	10	12.50	6	6.52	2.2	0.033	0.06
B*0801	3	3.75	1	1.08	3.6	0.033	0.02
B*1301	4	5.00	1	1.08	5.0	0.047	0.04
B*1801	1	1.25	2	1.08	0.6	0.0002
B*2705	2	2.50	1	1.08	2.4	0.02	0.01
B*3501	5	6.25	1	1.08	6.4	0.061	0.04		0.06
B*3503	2	2.50	6	6.52	0.4	0.009		0.03
B*3520	7	8.75	4	4.34	2.2	0.027	0.04
B*3701	3	3.75	1	1.08	3.6	0.033	0.02
B*4006	6	7.50	20	22.82	0.2	0.08		0.19	0.004*
B*4406	8	10.00	7	9.78	1.4	0.008	0.02
B*4801	2	2.50	1	1.08	2.4	0.02	0.01
B*510201	4	5.00	1	4.34	5.0	0.047	0.04
B*52011	7	8.75	6	6.52	1.4	0.009	0.02
B*5701	9	11.25	1	1.08	13.1	0.124	0.10		0.003*
Cw*0104	1	1.25	1	0.00	1.2	0.008
Cw*02021	3	3.75	2	2.17	1.8	0.013	0.01
Cw*03031	3	3.75	9	9.78	0.3	0.019		0.03
Cw*04011	10	12.50	18	19.56	0.5	0.015		0.06
Cw*0602	15	18.75	19	20.65	0.9	0.0002		0.03
Cw*0603	1	1.25	0	0.00	46.0
Cw*07011	6	7.50	4	4.34	1.9	0.018	0.03
Cw*0702	12	15.00	8	8.69	2.0	0.054	0.07
Cw*12021	20	25.00	4	4.34	10.5	0.236	0.16		2.05E-05†
Cw*15021	3	3.75	13	14.13	0.2	0.055		0.07	0.002*
Cw*1507	1	1.25	2	2.17	0.6	0.0002
Cw*16041	1	1.25	1	1.08	1.2	0.008

N+ - Number positive; AF (%) - allele frequency percentage; OR - Odds ratio; EF - Etiological fraction; PF - Preventive fraction

^*Significant P-value

^†Highly significant